Search Results - F. Volzone

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients by F. Forghieri, M. Luppi, M. Morselli, L. Potenza, F. Volzone, G. Riva, A. Imovilli, E. Rivolti, G. Torelli

    Published in Haematologica (2007-09-01)
    Get full text
    Article


  2. 2

    P024 | COMBINATION OF BASELINE CA125 LEVELS AND EOT FDG-PET DYNAMICALLY STRATIFIES FAILURE RISK IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA TREATED WITH DA-EPOCH-R: A REAL... by A. Fresa, M. Bonanni, A. Cuccaro, F. Ibello, D. Donnarumma, U. Falcone, M. Arcamone, S. Crisci, L. Sirica, M. Esposito, F. Volzone, C. Becchimanzi, S. Mele, R. De Filippi, A. Pinto

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  3. 3

    P020 | EXTENDED LEAD-IN PHASE OF BRENTUXIMAB VEDOTIN AND SHORTENED AVD IN OLDER PATIENTS (>60 YEARS) WITH ADVANCED HODGKIN LYMPHOMA (HL) AND HIGH COMORBIDITY BURDEN (ECOG≥2 AND/... by M. Bonanni, A. Cuccaro *, S. Mele *, E. Morelli, A. Fresa, M. Arcamone, F. Ibello, M. Esposito, M. Saggese, S. Crisci, M. Rivieccio, L. Simeone, F. Volzone, G. Corazzelli, R. De Filippi, A. Pinto

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  4. 4

    P023 | EFFICACY OF BISPECIFIC ANTIBODIES MOSUNETUZUMAB AND GLOFITAMAB IN B-CELL LYMPHOMA CELLS IS NOT AFFECTED BY THE RESISTANCE TO RITUXIMAB, OBINUTUZUMAB AND POLATUZUMAB. by S. Mele, S. Crisci, D. Galati, A. Fresa, A. Cuccaro, M. Bonanni, P. Maiolino, R. Azzaro, M. Saggese, M. Oro, S. Sarno, A. Altobelli, D. Donnarumma, F. Volzone, G. Marcacci, D. Mallardo, A. Pinto, R. De Filippi

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  5. 5

    S180: RG6234, A NOVEL GPRC5D T-CELL ENGAGING BISPECIFIC ANTIBODY, INDUCES RAPID RESPONSES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: PRELIMINARY RESULTS FROM A FIRST-IN... by C. Hasselbalch Riley, M. Hutchings, S.-S. Yoon, Y. Koh, S. Manier, T. Facon, S. J. Harrison, J. Er, F. Volzone, A. Pinto, C. Montes, E. M. Ocio, A. Alfonso-Pierola, P. Rodriguez Otero, F. Offner, A. Guidetti, P. Corradini, C. Titouan, C. Hulin, C. Touzeau, P. Moreau, R. Popat, S. Leong, R. Mazza, A.-M. E. Bröske, I. Dekhtiarenko, H.-J. Helms, S. Belli, T. Vardar, T. Fauti, J. Eckmann, T. Moore, M. Schneider, W. Jacob, M. Weisser, C. Carlo-Stella

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    S173: T-CELL ACTIVATION AND MYELOMA CELL KILLING CONFIRM THE MODE OF ACTION OF RG6234, A NOVEL GPRC5D T-CELL ENGAGING BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULT... by I. Dekhtiarenko, I. Lelios, J. Attig, N. Sleiman, D. Lazzaro, I. Clausen, N. Gräfe, H.-J. Helms, E. Schindler, S. Belli, T. Fauti, J. Eckmann, P. Umana, W. Jacob, M. Schneider, C. Hasselbalch Riley, M. Hutchings, S.-S. Yoon, Y Koh, S. Manier, T. Facon, S. J. Harrison, J. Er, F. Volzone, A. Pinto, C. Montes, E. M. Ocio, A. Alfonso-Pierola, P. Rodríguez Otero, F. Offner, A. Guidetti, P. Corradini, C. Titouan, C. Hulin, C. Touzeau, P. Moreau, R. Popat, S. Leong, R. Mazza, C. Carlo-Stella, A.-M. E. Bröske

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: